Clinical Topics & News
Eruptive Collagenomas, Suprasellar Meningioma, and Elevated Prolactin in a Patient With a History of Papillary Thyroid Carcinoma
Fed Pract. 2011 December;28(12):25
Author and Disclosure Information
Jerry J. Fasoldt, MD; and Eric P. Brumwell, MD
Connective tissue nevi are defined as hamartomas of dermal connective tissue components.1 They are classified according to the extracellular connective tissue component that predominates. In collagenomas, collagen is most prevalent; whereas other connective tissue nevi can consist of excess elastin fibers or glycosaminoglycans.2 Collagenomas can occur in many different clinical scenarios, and in this report, we describe a unique case of eruptive collagenomas occurring in a patient with a concurrent suprasellar meningioma, an elevated prolactin level, and a previous history of papillary thyroid cancer.
Recommended Reading
Clinical Topics
-
When cisplatin won’t do, try carboplatin in head and neck cancer -
Is early-onset cancer an emerging global epidemic? Publish date: October 5, 2022 -
Despite benefits, extended-interval pembro uptake remains low Publish date: September 28, 2022 -
Time to cancer diagnoses in U.S. averages 5 months Publish date: September 15, 2022 -
Trends in Palliative Care Utilization and Facility Type for Stage IV Esophageal Cancer: A National Cancer Database Analysis
Digital Edition
-
Publish date: September 22, 2021
-
Publish date: September 3, 2021
-
Publish date: May 20, 2021
-
-
Multimedia
-
Publish date: September 14, 2014
Conference Coverage
-
A farewell to arms? Drug approvals based on single-arm trials can be flawed Publish date: September 19, 2022 -
Time to cancer diagnoses in U.S. averages 5 months Publish date: September 15, 2022 -
Pembro/chemo combo fails to improve event-free survival in head and neck cancer Publish date: September 14, 2022 -
First drug for desmoid tumors: ‘Impressive’ data for nirogacestat Publish date: September 13, 2022 -
Collagen ‘tile’ delivers postsurgical radiation in glioblastoma Publish date: June 10, 2022 -
Can liquid biopsy predict oropharyngeal cancer recurrence? Publish date: March 3, 2022 -
Confirmed: Pembro plus chemo as first-line standard of care for esophageal cancer Publish date: February 1, 2022 -
Many patients, doctors unaware of advancements in cancer care Publish date: October 4, 2021 -
Most community-based oncologists skip biomarker testing Publish date: September 21, 2021 -
Publish date: May 3, 2021
ATA Guidelines: Lymph node dissection & DTC

Question 1 of 5